Prescription for Trouble: Addressing Drug Safety Issues in Supply Chains for Seniors - September 17, 2025

This Senate Aging Committee hearing examines vulnerabilities in pharmaceutical supply chains, particularly the risks posed by foreign manufacturing of generic drugs to aging Americans, focusing on quality control, shortages, and strategies to enhance domestic production and safety.

Witnesses
Peter Baker, Former FDA Inspector, President, Live Oak Quality Assurance, Austin, TX
George Ball, PhD, Associate Professor and Weimer Faculty Fellow, Kelley School of Business, Indiana University, Bloomington, IN
Brandon Daniels, CEO, Exiger, Washington, DC
Ronald Piervincenzi PhD, CEO, U.S. Pharmacopeia, Washington, DC